Trial Profile
Induction Therapy for Locally Advanced, Resectable Cancer of the Esophagus, Gastroesophageal (GE) Junction and Gastric Cancer: A Phase I Trial of ZD6474 (Zactima, Vandetanib), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Vandetanib (Primary) ; Carboplatin; Fluorouracil; Paclitaxel
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer; Squamous cell cancer
- Focus Adverse reactions
- 01 Aug 2017 Status changed from recruiting to completed, based on the results published in the American Journal of Clinical Oncology.
- 01 Aug 2017 Results published in the American Journal of Clinical Oncology.
- 03 Sep 2010 New trial record